Fournier Laboratories withdraws its marketing authorisation application for Synordia

The European Medicines Agency (EMEA) has been formally notified by Fournier Laboratories Ireland Ltd of their decision to withdraw its application for a centralised marketing authorisation for the medicinal product Synordia (fenofibrate/metformin hydrochloride).

Synordia was expected to be used as an adjunct to changes to diet and exercise to improve glycaemic control and dyslipidaemia in patients with type 2 diabetes mellitus. It was intended for use in patients who require both fenofibrate and metformin and have already been stabilised on each drug.

The application for marketing authorisation for Synordia was submitted to the EMEA on 17 July 2006. At the time of the withdrawal, it was under review by the Agency's Committee for Medicinal Products for Human Use (CHMP).

In its official letter, the company stated that the withdrawal of Synordia was due to the fact that it is not able to respond to the request for additional information within the allowed timeframe.

More information about Synordia and the current state of the scientific assessment at the time of withdrawal will be made available in a question and answer document. This document, together with the withdrawal letter from the company, will be published on the EMEA website after the next meeting of the CHMP on 11-14 December 2006.


1. Withdrawal of an application does not prejudice the possibility of a company making a new application at a later stage.
2. This press release, together with other information about the work of the EMEA, may be found on the EMEA website: <>

Media enquiries only to:
Martin Harvey Allchurch or Monika Benstetter
Tel: (44-20) 74 18 84 27, E-mail: <>

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Just published

GP typing at computer

GP practices asked to switch on data sharing with UK Biobank

GP practices have been asked to share patient data with the biomedical database UK...

Child vaccination

'Serious concern' as child vaccination rates slip and MMR hits new low

Health officials have voiced 'serious concern' after child vaccination rates in England...

Talking General Practice logo

Podcast: GP contract trends, the future of physician associates, cost-of-living impact on patient health

The team discusses what recent tenders for GP contracts tell us about the possible...

GP consultation

GP practices delivering 150,000 extra appointments per day compared with 2019

GP practices in England delivered 150,000 more appointments per working day in the...

Surgeon looking at a monitor in an operating theatre

NICE recommends non-invasive surgical procedure to target obesity

NICE has said that a non-invasive weight loss procedure should be used by the NHS...

GP trainee

Two training posts deliver one full-time GP on average, report warns

Two training posts are needed on average to deliver a single fully-qualified, full-time...